Mercy BioAnalytics
Monday, February 26, 2024
Plymouth
Diagnostics
Mercy BioAnalytics is a pre-commercial diagnostics company on a mission to save lives and relieve suffering through the early detection of cancer. We are developing ,broadly accessible, inexpensive, blood-based screening tests, initially focused on two critical areas of unmet need: detection of lung and ovarian cancer in patients who are at higher risk. At Mercy, we believe all those at higher risk for developing cancer should have access to high performing, affordable screening tests, and are committed to advancing our innovative portfolio of tests towards global clinical impact.
State
Massachusetts
Country
United States
Website
https://mercybio.com/
CEO/Top Company Official
Dr. Dawn Mattoon
Lead Product in Development
Mercy Halo Lung Cancer Test, intended to screen patients at high risk of developing lung cancer due to smoking history
Development Phase of Primary Product
Other/Not Applicable
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
)
)
){kind=logo}